FORMULE L9 LIQ DIN 00460079
Health Canada record
| Active ingredient(s) | GLYCYRRHIZA GLABRA 64.5 MG; CASCARA SAGRADA 33.2 MG; PHYTOLACCA DECANDRA 33.2 MG; STILLINGIA 33.2 MG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1979 |
| Current status date | 11-May-2010 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GLYCYRRHIZA GLABRA
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02234520 | GLYCYRRHIZA GLABRA | DOLISOS CANADA INC. | Globules; Granules; Liquid | GLYCYRRHIZA GLABRA 1 X | Cancelled Post Market |
| 00898090 | GLYCYRRHIZA GLABRA DPS ((1X-1000C)) | THOMPSON'S HOMEOPATHIC SUPPLIES LTD. | Drops | GLYCYRRHIZA GLABRA 1 X | Cancelled Post Market |
| 00125520 | LIQUISAN SYR FOR COUGH NO2 | A G KUNZLE KRAUTERPFARRER AG | Syrup | GLYCYRRHIZA GLABRA 3 %; PIMPINELLA SAXIFRAGA 3 %; ANISE 2 %; THYME 2 % | Cancelled Post Market |